|
Aggregated analysis of 1,000 patients with cancer to assess the benefits of integrated whole exome and whole transcriptome sequencing. |
|
|
|
Patents, Royalties, Other Intellectual Property - BostonGene |
|
|
|
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - BostonGene |
Patents, Royalties, Other Intellectual Property - BostonGene |
|
|
|
|
|
|
Stock and Other Ownership Interests - BostonGene |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - BostonGene |
Patents, Royalties, Other Intellectual Property - BostonGene |
|
|
|
Stock and Other Ownership Interests - BostonGene |
|
|
|
Stock and Other Ownership Interests - BostonGene |
Patents, Royalties, Other Intellectual Property - BostonGene |
|
|
No Relationships to Disclose |